AlphAIAlphAI — Financial news for AI agents
quiverquant.comOCT 61 min read$TLRY

TILRAY Q1 2027 Earnings Preview: Recent $TLRY Insider Trading, Hedge Fund Activity, and More

TILRAY ($TLRY) is set to report Q1 2027 earnings on October 8th, with analysts expecting $273.92M revenue and -$0.19 EPS. Insiders traded $TLRY 4 times in the past 6 months, with 3 purchases and 1 sale. Hedge funds have mixed activity, with 96 adding shares and 74 decreasing positions. Q4 2026 revenue was $281.7M, up 25.47% YoY.

Original reporting
quiverquant.com
Published Oct 6, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 6:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
TILRAY Q1 2027 Earnings Preview: Recent $TLRY Insider Trading, Hedge Fund Activity, and More — source image
Source · quiverquant.com
Decision brief

The 30-second read

$TLRYBearishLow
01

Why it matters

The preview suggests a likely negative bias ahead of the earnings release, but unexpected positive results could trigger a short squeeze.

02

Market read

Earnings preview with expected loss; modest trading relevance for short‑term traders.

03

What to watch

Potential impact of recent hedge fund buying could offset insider sell pressure.

Relevance 4/10Novelty 2/10Timing: pre‑market Oct 8

Background

Tilray (TLRY) is a publicly traded cannabis producer. The article provides a preview of its upcoming earnings and recent insider/hedge fund activity.

Company-level read

Ticker impact

$TLRYBearishMedium confidence
Context

The article previews Tilray's Q1 2027 earnings scheduled for Oct 8, providing expected revenue and EPS, plus recent insider and hedge fund activity.

Expected impact

likely pressure as the market prices in the anticipated loss

Evidence & confidence

Negative EPS guidance and recent insider sales may weigh on the stock ahead of the release.

Market effects

Sector

Limited; Tilray is a cannabis company and its earnings may affect peer sentiment but no broad sector impact.

Regional

North American cannabis market focus; minimal regional effect.

Global

Low; the preview is company‑specific.

Counterpoint

What could challenge this read

If Tilray beats the loss forecast, the stock could rally sharply on surprise upside.

Key entities

  • Company
    Tilray

    US‑listed cannabis producer (ticker TLRY).

Read at source← All news

Related articles

OCT 9
$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

cantechletter.com2 min
OCT 9
$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

foodbusinessmea.com2 min
OCT 9
$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

finance.yahoo.com2 min
OCT 8
$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

finance.yahoo.com2 min
OCT 8
$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.

stocktitan.net2 min